ArticleScientific reports2025
The impact of PANoptosis-related genes on immune profiles and subtype classification in ischemic stroke.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
Abstract
Ischemic stroke (IS) is an acute neurological disorder causing brain dysfunction, with high mortality and disability. PANoptosis is a synchronized sort of regulated cell demise that combines the characteristics of pyroptosis, apoptosis, and necroptosis. However, its role in ischemic stroke remains unclear. We downloaded the ischemic stroke-related microarray dataset GSE58294 from the Gene Expression Omnibus (GEO) database and identified Differentially expressed PANoptosis-related genes (DE-PRGs). We utilized three algorithms to identify diagnostic DE-PRGs, constructed a nomogram for diagnostic modeling, and evaluated their diagnostic performance with receiver operating characteristic (ROC) analysis. Additionally, we develop interaction networks linking genes with miRNAs, transcription factors, and drugs. We also analyzed gene expression in different cell subgroups using the GSE174574 single-cell dataset. We applied consensus clustering to classify stroke samples into subtypes and compared immune microenvironment differences. Ultimately, we verified the gene expression patterns of candidate markers through the MCAO model. We pinpointed seven diagnostic DE-PRGs, with CASP1, PIK3R5, AVEN, and PSMC3 showing significant protein expression differences. Single-cell transcriptome analysis revealed the link between stroke and immune cells. Furthermore, consensus clustering revealed two clusters with unique immune infiltration patterns and functional characteristics. Our study may provide new theoretical insights for the early diagnosis and targeted therapy of IS and offer support for the clinical application of PANoptosis in IS.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.